Works matching AU Habermann, Thomas

Results: 200
    1

    Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.

    Published in:
    Cancer Causes & Control, 2012, v. 23, n. 7, p. 1017, doi. 10.1007/s10552-012-9967-0
    By:
    • Kelly, Jennifer;
    • Drake, Matthew;
    • Fredericksen, Zachary;
    • Asmann, Yan;
    • Liebow, Mark;
    • Shanafelt, Tait;
    • Feldman, Andrew;
    • Ansell, Stephen;
    • Macon, William;
    • Herr, Megan;
    • Wang, Alice;
    • Nowakowski, Grzegorz;
    • Call, Timothy;
    • Habermann, Thomas;
    • Slager, Susan;
    • Witzig, Thomas;
    • Cerhan, James
    Publication type:
    Article
    2
    3

    Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 3, p. 396, doi. 10.1002/ijc.34266
    By:
    • Boyle, Terry;
    • Kleinstern, Geffen;
    • Bracci, Paige M.;
    • Cerhan, James R.;
    • Benavente, Yolanda;
    • Casabonne, Delphine;
    • Chiu, Brian C.‐H.;
    • Habermann, Thomas M.;
    • Holly, Elizabeth A.;
    • Liebow, Mark;
    • Norman, Aaron;
    • Paltiel, Ora;
    • Robinson, Dennis;
    • Rothman, Nathaniel;
    • Abu Seir, Rania;
    • Slager, Susan L.;
    • Villeneuve, Paul J.;
    • Wang, Sophia S.;
    • Weisenburger, Dennis D.;
    • Spinelli, John J.
    Publication type:
    Article
    4
    5

    Author reply.

    Published in:
    2000
    By:
    • Fonseca, Rafael;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Egan, Kathleen S.;
    • Fonseca, R;
    • Inwards, DJ;
    • Habermann, TM;
    • Egan, KS
    Publication type:
    journal article
    6

    Testicular lymphoma is associated with a high incidence of extranodal recurrence.

    Published in:
    2000
    By:
    • Fonseca, Rafael;
    • Habermann, Thomas M.;
    • Colgan, Joseph P.;
    • O'Neill, Brian P.;
    • White, William L.;
    • Witzig, Thomas E.;
    • Egan, Kathleen S.;
    • Martenson, James A.;
    • Burgart, Lawrence J.;
    • Inwards, David J.;
    • Fonseca, R;
    • Habermann, T M;
    • Colgan, J P;
    • O'Neill, B P;
    • White, W L;
    • Witzig, T E;
    • Egan, K S;
    • Martenson, J A;
    • Burgart, L J;
    • Inwards, D J
    Publication type:
    journal article
    7
    8

    CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1475, doi. 10.1007/s00262-013-1452-4
    By:
    • Charbonneau, Bridget;
    • Wang, Alice;
    • Maurer, Matthew;
    • Asmann, Yan;
    • Zent, Clive;
    • Link, Brian;
    • Ansell, Stephen;
    • Weiner, George;
    • Ozsan, Nazan;
    • Feldman, Andrew;
    • Witzig, Thomas;
    • Cunningham, Julie;
    • Dogan, Ahmet;
    • Habermann, Thomas;
    • Slager, Susan;
    • Novak, Anne;
    • Cerhan, James
    Publication type:
    Article
    9
    10
    11
    12

    Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 4, p. e183, doi. 10.1016/j.clml.2024.11.014
    By:
    • Nastoupil, Loretta J.;
    • Andersen, Clark R.;
    • Ayers, Amy;
    • Yucai Wang;
    • Habermann, Thomas M.;
    • Dai Chihara;
    • Kahl, Brad S.;
    • Link, Brian K.;
    • Koff, Jean L.;
    • Cohen, Jonathon B.;
    • Martin, Peter;
    • Lossos, Izidore S.;
    • Stanchina, Michele;
    • Haddadi, Sara;
    • Casulo, Carla;
    • Ayyappan, Sabarish;
    • Ruitao Lin;
    • Ziyi Li;
    • Larson, Melissa A.;
    • Maurer, Matthew J.
    Publication type:
    Article
    13

    Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
    By:
    • Okcu, Izel;
    • Yucai Wang;
    • Bock, Allison M.;
    • Jihao Zhou;
    • Moustafa, Muhamad Alhaj;
    • Tun, Han W.;
    • Rosenthal, Allison C.;
    • Johnston, Patrick B.;
    • Baidoun, Firas;
    • Khurana, Arushi;
    • Kabat, Brian F.;
    • King, Rebecca L.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    14

    Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
    By:
    • Kuhlman, Justin J.;
    • Moustafa, Muhamad Alhaj;
    • Jiang, Liuyan;
    • Iqbal, Madiha;
    • Seegobin, Karan;
    • Wolcott, Zoe;
    • Ayala, Ernesto;
    • Ansell, Steve;
    • Rosenthal, Allison;
    • Paludo, Jonas;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Inwards, David;
    • Habermann, Thomas;
    • Kharfan-Dabaja, Mohamed;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Tun, Han W.
    Publication type:
    Article
    15
    16

    IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    17
    18

    Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    19

    Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
    By:
    • Bock, Allison M.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Sarangi, Vivek;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • King, Rebecca L.;
    • Farooq, Umar;
    • Wang, Yucai;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Gandhi, Anita K.
    Publication type:
    Article
    28

    Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
    By:
    • Hopper, Melissa A.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Novak, Joseph P.;
    • Manske, Michelle K.;
    • Serres, MaKayla R.;
    • Sarangi, Vivekananda;
    • Larson, Melissa C.;
    • Maurer, Matthew J.;
    • Yang, Zhi‐Zhang;
    • Paludo, Jonas;
    • McPhail, Ellen D.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Rimsza, Lisa M.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Jevremovic, Dragan
    Publication type:
    Article
    29
    30
    31

    Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
    By:
    • Kraft, Robert M.;
    • Ansell, Stephen M.;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Thanarajasingam, Gita;
    • Lester, Scott C.;
    • Macon, William;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Micallef, Ivana N.;
    • Witzig, Thomas E.;
    • Thompson, Carrie A.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Lin, Yi;
    • Paludo, Jonas
    Publication type:
    Article
    32
    33

    FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.

    Published in:
    2017
    By:
    • Ghesquières, Hervé;
    • Larrabee, Beth R.;
    • Haioun, Corinne;
    • Link, Brian K.;
    • Verney, Aurélie;
    • Slager, Susan L.;
    • Ketterer, Nicolas;
    • Ansell, Stephen M.;
    • Delarue, Richard;
    • Maurer, Matthew J.;
    • Fitoussi, Olivier;
    • Habermann, Thomas M.;
    • Peyrade, Fréderic;
    • Dogan, Ahmet;
    • Molina, Thierry J.;
    • Novak, Anne J.;
    • Tilly, Hervé;
    • Cerhan, James R.;
    • Salles, Gilles;
    • Ghesquières, Hervé
    Publication type:
    journal article
    34
    35
    36

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    37
    38
    39

    Body mass index and survival of patients with lymphoma.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2671, doi. 10.1080/10428194.2021.1929956
    By:
    • Chihara, Dai;
    • Larson, Melissa C.;
    • Robinson, Dennis P.;
    • Thompson, Carrie A.;
    • Maurer, Matthew J.;
    • Casulo, Carla;
    • Pophali, Priyanka;
    • Link, Brian K.;
    • Habermann, Thomas M.;
    • Feldman, Andrew L.;
    • Flowers, Christopher R.;
    • Cerhan, James R.;
    • Morton, Lindsay M.
    Publication type:
    Article
    40
    41
    42

    Blood Transfusion and Risk of Non-Hodgkin's Lymphoma.

    Published in:
    American Journal of Epidemiology, 2009, v. 149, n. 12, p. 1113
    By:
    • Maguire-Boston, Eryn K.;
    • Suman, Vera;
    • Jacobsen, Steve J.;
    • Moore, S. Breanndan;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Folsom, Aaron R.
    Publication type:
    Article
    43

    Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.

    Published in:
    International Journal of Dermatology, 2002, v. 41, n. 6, p. 352, doi. 10.1111/j.1365-4632.2002.01501.x
    By:
    • Bouwhuis, Saskia A.;
    • el-Azhary, Rokea A.;
    • McEvoy, Marian T.;
    • Gibson, Lawrence E.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Pittelkow, Mark R.
    Publication type:
    Article
    44
    45

    Management of Stage IE Primary Gastric Lymphoma.

    Published in:
    Acta Haematologica, 1995, v. 94, n. 2, p. 59, doi. 10.1159/000203975
    By:
    • Durr, Dolores;
    • Bonner, James A.;
    • Strickler, John G.;
    • Martenson, James A.;
    • Chen, Michael G.;
    • Habermann, Thomas M.;
    • Donohue, John H.;
    • Earle, John D.;
    • Grill, Joseph P.
    Publication type:
    Article
    46
    47

    Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 4, p. 661, doi. 10.1111/bjh.16425
    By:
    • Jakobsen, Lasse H.;
    • Ellin, Fredrik;
    • Smeland, Knut B.;
    • Wästerlid, Tove;
    • Christensen, Jacob H.;
    • Jørgensen, Judit M.;
    • Josefsson, Pär L.;
    • Øvlisen, Andreas K.;
    • Holte, Harald;
    • Blaker, Yngvild N.;
    • Grauslund, Jacob H.;
    • Bjørn, Jon;
    • Molin, Daniel;
    • Lagerlöf, Ingemar;
    • Smedby, Karin E.;
    • Colvin, Katherine;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Song, Kevin W.
    Publication type:
    Article
    48

    Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kumar, Shaji;
    • Manske, Michelle;
    • Novak, Anne J.;
    • King, Rebecca;
    • Greipp, Patricia;
    • Go, Ronald;
    • Inwards, David;
    • Muchtar, Eli;
    • Habermann, Thomas;
    • Witzig, Thomas E.;
    • Thompson, Carrie A.;
    • Dingli, David;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Dispenzieri, Angela;
    • Gonsalves, Wilson
    Publication type:
    Article
    49
    50

    Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.

    Published in:
    British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
    By:
    • Hill, Brian T.;
    • Nastoupil, Loretta;
    • Winter, Allison M.;
    • Becnel, Melody R.;
    • Cerhan, James R.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Maurer, Matthew J.;
    • Fakhri, Bita;
    • Reddy, Prathima;
    • Smith, Stephen D.;
    • Mukhija, Dhruvika;
    • Jagadeesh, Deepa;
    • Desai, Amrita;
    • Alderuccio, Juan Pablo;
    • Lossos, Izidore S.;
    • Mehra, Pooja;
    • Portell, Craig A.;
    • Goldman, Max L.;
    • Calzada, Oscar
    Publication type:
    Article